Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

Talk around weight in the United States has reached a fever pitch thanks to the popularity of injectable GLP-1 medications, ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Share on Facebook Share on Twitter If it seems like Morgan Wallen is number one on a lot of Billboard charts, it’s because he ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

The actress, who played Brooke Armstrong on the soap opera, said there was a "thinness situation" on filming sets at the time ...

Dogecoin price drops 14% to $0.25 amid bearish market, with heightened trading activity. A potential rebound to $0.34 is ...

The aftershock of the release of DeepSeek’s models hit the stock market Monday. Shares of Nvidia, which has seen its sales ...

On Wall Street, all eyes are on Nvidia Corp.’s stock as chart-watchers search for signs the chipmaking giant will resume a ...

The outperformance of the US stock market against its global peers in recent years is widely commented on, as well as the ever-widening gap between valuation multiples in the US and elsewhere – ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.